Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-087395

SUPERNUS PHARMACEUTICALS, INC. · SUPN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jack A. Khattar
Officer — President, CEO · Director
Period of report
Dec 28, 2015
Accepted (ET)
Dec 30, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Dec 28, 2015G1,000$0.00D438,434D
Common StockDec 28, 2015G1,000$0.00D437,434D
Common StockDec 28, 2015G1,000$0.00D436,434D
Common StockDec 28, 2015G1,000$0.00A2,250IBy son
Common Stockholding———1,101,000IBy the KBT Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses